Santa Cruz Biotechnology provides a broad selection of CD45RO monoclonal antibodies for studying immune cell activation and differentiation. CD45RO monoclonal antibodies perform effectively in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD45RO, a member of the protein tyrosine phosphatase family, plays a critical role in regulating T cell activation and signaling. CD45RO is primarily expressed on memory T cells, making it a key marker for understanding immune responses and the development of immunological memory. The study of CD45RO contributes significantly to research in autoimmune diseases, cancer immunology, and vaccine development. Researchers investigating T cell biology can explore cellular mechanisms and pathways using CD45RO monoclonal antibodies. Understanding CD45RO function helps advance therapeutic strategies for immune-related conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system dynamics and potential therapeutic applications.